|
Orthologous residues
|
|
PLCG2 (human): Y753‑p, PLCG2 (mouse): Y753‑p, PLCG2 (rat): Y753‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mass spectrometry, mutation of modification site, phospho-antibody
|
|
Relevant cell lines - cell types - tissues:
DT40 (B lymphocyte)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
chicken
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
H2O2
|
|
|
|
increase
|
|
|
anti-IgM
|
|
|
|
increase
|
|
|